Factor VII coagulant activity, factor VII -670A/C and -402G/A polymorphisms, and risk of venous thromboembolism

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 8, 2007, Pages 1674-1678

  Folsom, Aaron R ^a   Cushman, M ^b   Heckbert, S R ^c   Ohira, T ^a   Rasmussen Torvik, L ^a   Tsai, M Y ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Blood coagulation factors; Factor VII; Prospective study; Pulmonary embolus; Venous thrombosis

Indexed keywords

ADENINE; BLOOD CLOTTING FACTOR 7; CYTOSINE; GUANINE;

ADULT; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HIGH RISK PATIENT; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM;

ALLELES; ANTIGENS; COAGULANTS; FACTOR VII; FEMALE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 34447646483     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02620.x     Document Type: Article

References (20)

1. Lowe GD. Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture. Br J Haematol 2006; 133: 232-50.
2. Koster T, Rosendaal FR, Reitsma PH, van der Velden PA, Briet E, Vandenbroucke JP. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms-the Leiden Thrombophilia Study (LETS). Thromb Haemost 1994; 71: 719-22.
3. Lowe G, Woodward M, Vessey M, Rumley A, Gough P, Daly E. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy. Thromb Haemost 2000; 83: 530-5.
4. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Tracy R, Aleksic N, Folsom AR. Coagulation factors, inflammation markers, and venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE). Am J Med 2002; 113: 636-42.
5. van't Hooft FM, Silveira A, Tornvall P, Iliadou A, Ehrenborg E, Eriksson P, Hamsten A. Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration. Blood 1999; 93: 3432-41.
6. Lindman AS, Pedersen JI, Hjerkinn EM, Veierød MB, Kavlie A, Arnesen H, Seljeflot I. The influence of the -401G/T and -402G/A polymorphisms of the coagulation FVII promoter on plasma levels of FVII. Thromb Res 2005; 116: 313-20.
7. Carew JA, Basso F, Miller GJ, Hawe E, Jackson AA, Humphries SE, Bauer KA. A functional haplotype in the 5′ flanking region of the factor VII gene is associated with an increased risk of coronary heart disease. J Thromb Haemost 2003; 1: 2179-85.
8. Lindman AS. Association between the factor VII haplotype containing the -402A allele and myocardial infarction in a population of elderly men at high risk for coronary heart disease. Thromb Haemost 2005; 94: 226-7 (Letter).
9. Bozzini C, Girelli D, Bernardi F, Ferraresi P, Olivieri O, Pinotti M, Martinelli N, Manzato F, Friso S, Villa G, Pizzolo F, Beltrame F, Corrocher R. Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis. Thromb Haemost 2004; 92: 541-9.
10. Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P, Folsom AR. Deep vein thrombosis and pulmonary embolism in two cohorts: the Longitudinal Investigation of Thromboembolism Etiology. Am J Med 2004; 117: 19-25.
11. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: The Longitudinal Investigation of Thromboembolism Etiology (LITE) Study. Arch Intern Med 2002; 162: 1182-9.
12. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997; 96: 1102-8.
13. Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP. Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem 1995; 41: 264-70.
14. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
15. de Ronde H, Bertina R. Laboratory diagnosis of APC-resistance: A critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994; 72: 880-6.
16. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 91: 191-205.
17. Tracy RP, Bovill EG, Fried LP, Heiss G, Lee MH, Polak JF, Psat BM, Savage PJ, for the CHS Investigators. The distribution of coagulation factors VII and VIII and fibrinogen in adults over 65 years. Results from the Cardiovascular Health Study. Ann Epidemiol 1992; 2: 509-19.
18. Green D, Ruth KJ, Folsom AR, Liu K. Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arterioscler Thromb 1994; 14: 686-93.
19. Cushman M, Yanez D, Psaty BM, Fried LP, Heiss G, Lee M, Polak JF, Savage PJ, Tracy RP, for the Cardiovascular Health Study Investigators. Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly. Am J Epidemiol 1996; 143: 665-76.
20. Zee RYL, Cook NR, Cheng S, Erlich HA, Lindpaintner K, Ridker PM. Polymorphism in the β; 2 -adrenergic receptor and lipoprotein lipase genes as risk determinants for idiopathic venous thromboembolism. A multilocus, population-based, prospective genetic analysis. Circulation 2006; 113: 2193-200.